K170399 is an FDA 510(k) clearance for the Endoskeleton TO Interbody Fusion Device (IBD). Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.
Submitted by Titan Spine, LLC (Mequon, US). The FDA issued a Cleared decision on July 6, 2017 after a review of 147 days - within the typical 510(k) review window.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Titan Spine, LLC devices